Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin vs TPC in Advanced NSCLC
NCT01454934Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of eribulin in non-small cell lung cancer (NSCLC), sponsored by Eisai Co., Ltd.. Started Dec 2011; status: completed.
02
Drugs
eribulin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01454934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01454934.